aTyr Pharma Inc (LIFE)
1.62
-0.02
(-1.22%)
USD |
NASDAQ |
Apr 23, 16:00
1.62
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Net Income (Quarterly): -14.76M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.76M |
| September 30, 2023 | -11.34M |
| June 30, 2023 | -12.34M |
| March 31, 2023 | -11.95M |
| December 31, 2022 | -7.521M |
| September 30, 2022 | -13.24M |
| June 30, 2022 | -12.42M |
| March 31, 2022 | -12.15M |
| December 31, 2021 | -8.559M |
| September 30, 2021 | -7.667M |
| June 30, 2021 | -10.39M |
| March 31, 2021 | -7.151M |
| December 31, 2020 | -4.932M |
| September 30, 2020 | -6.599M |
| June 30, 2020 | -6.446M |
| March 31, 2020 | 1.753M |
| December 31, 2019 | -5.973M |
| September 30, 2019 | -5.645M |
| June 30, 2019 | -5.848M |
| March 31, 2019 | -6.137M |
| Date | Value |
|---|---|
| December 31, 2018 | -6.322M |
| September 30, 2018 | -7.114M |
| June 30, 2018 | -10.41M |
| March 31, 2018 | -10.67M |
| December 31, 2017 | -11.47M |
| September 30, 2017 | -11.19M |
| June 30, 2017 | -12.14M |
| March 31, 2017 | -13.40M |
| December 31, 2016 | -12.57M |
| September 30, 2016 | -13.82M |
| June 30, 2016 | -15.38M |
| March 31, 2016 | -16.09M |
| December 31, 2015 | -16.49M |
| September 30, 2015 | -11.33M |
| June 30, 2015 | -11.08M |
| March 31, 2015 | -9.071M |
| December 31, 2014 | -6.038M |
| September 30, 2014 | -6.631M |
| June 30, 2014 | -5.588M |
| March 31, 2014 | -6.093M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-14.76M
Minimum
Dec 2023
1.753M
Maximum
Mar 2020
-8.589M
Average
-7.667M
Median
Sep 2021
Net Income (Quarterly) Benchmarks
| Vaxart Inc | -17.38M |
| Allogene Therapeutics Inc | -89.26M |
| AIM ImmunoTech Inc | -12.58M |
| Protalix BioTherapeutics Inc | -6.044M |
| Armata Pharmaceuticals Inc | -19.85M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 15.96M |
| EPS Diluted (Quarterly) | -0.25 |
| Enterprise Value | 11.40M |
| Earnings Yield | -59.26% |
| Normalized Earnings Yield | -59.88 |